80 FR 12262 - Notice of Intent To Grant an Exclusive License

DEPARTMENT OF VETERANS AFFAIRS

Federal Register Volume 80, Issue 44 (March 6, 2015)

Notice is hereby given that the Department of Veterans Affairs, Office of Research and Development, intends to grant to Rubicon Biotechnology, LLC, 26212 Dimension Dr. Suite 260, Lake Forest, CA 92630, USA, an exclusive license to practice the following: U.S. Patent Application Serial No. 13/815,829 (``ANTIBODY-MEDIATED TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS''), filed March 15, 2013, which claimed the priority of U.S. Serial No. 61/618,594, filed March 30, 2012. Copies of the published patent applications may be obtained from the U.S. Patent and Trademark Office at www.uspto.gov.

[Federal Register Volume 80, Number 44 (Friday, March 6, 2015)]
[Notices]
[Page 12262]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-05209]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Notice of Intent To Grant an Exclusive License

AGENCY: Office of Research and Development, Department of Veterans 
Affairs.

ACTION: Notice of Intent.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Department of Veterans 
Affairs, Office of Research and Development, intends to grant to 
Rubicon Biotechnology, LLC, 26212 Dimension Dr. Suite 260, Lake Forest, 
CA 92630, USA, an exclusive license to practice the following: U.S. 
Patent Application Serial No. 13/815,829 (``ANTIBODY-MEDIATED 
TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS''), filed March 
15, 2013, which claimed the priority of U.S. Serial No. 61/618,594, 
filed March 30, 2012. Copies of the published patent applications may 
be obtained from the U.S. Patent and Trademark Office at www.uspto.gov.

DATES: Comments must be received 15 days from the date of this 
published Notice.

ADDRESSES: Written comments may be submitted through 
www.regulations.gov; by mail or hand-delivery to the Director, 
Regulations Management (02REG), Department of Veterans Affairs, 810 
Vermont Avenue NW., Room 1068, Washington, DC, 20420; or by fax to 
(202) 273-9026. Copies of comments received will be available for 
public inspection in the Office of Regulation Policy and Management, 
Room 1063B, between the hours of 8:00 a.m. and 4:30 p.m., Monday 
through Friday (except holidays). Call (202) 461-4902 for an 
appointment (this is not a toll-free number). In addition, during the 
comment period, comments may be viewed online through the Federal 
Docket Management System at http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Dr. Lee A. Sylvers, Technology 
Transfer Specialist, Office of Research and Development (10P9TT), 
Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC, 
20420, (202) 443-5646 (this is not a toll-free number).

SUPPLEMENTARY INFORMATION: It is in the public interest to so license 
these inventions, as Rubicon Biotechnology, LLC submitted a complete 
and sufficient application for a license. The prospective exclusive 
license will be royalty-bearing and will comply with the terms and 
conditions of 35 U.S.C. 209 and 37 CFR 404.7.

Signing Authority

    The Secretary of Veterans Affairs, or designee, approved this 
document and authorized the undersigned to sign and submit the document 
to the Office of the Federal Register for publication electronically as 
an official document of the Department of Veterans Affairs. Jose D. 
Riojas, Chief of Staff, approved this document on March 2, 2015 for 
publication.

    Approved: March 3, 2015.
Michael Shores,
Regulation Policy and Management, Office of General Counsel.
[FR Doc. 2015-05209 Filed 3-5-15; 8:45 am]
 BILLING CODE 8320-01-P